More than cholesterol catabolism: regulatory vulnerabilities in Mycobacterium tuberculosis
- PMID: 29906645
- PMCID: PMC6005656
- DOI: 10.1016/j.cbpa.2018.05.012
More than cholesterol catabolism: regulatory vulnerabilities in Mycobacterium tuberculosis
Abstract
Mycobacterium tuberculosis (Mtb) is the epitome of persistent. Mtb is the pathogen that causes tuberculosis, the leading cause of death by infection worldwide. The success of this pathogen is due in part to its clever ability to adapt to its host environment and its effective manipulation of the host immune system. A major contributing factor to the survival and virulence of Mtb is its acquisition and metabolism of host derived lipids including cholesterol. Accumulating evidence suggests that the catabolism of cholesterol during infection is highly regulated by cholesterol catabolites. We review what is known about how regulation interconnects with cholesterol catabolism. This framework provides support for an indirect approach to drug development that targets Mtb cholesterol metabolism through dysregulation of nutrient utilization pathways.
Copyright © 2018 Elsevier Ltd. All rights reserved.
Figures



Similar articles
-
Pathogen roid rage: cholesterol utilization by Mycobacterium tuberculosis.Crit Rev Biochem Mol Biol. 2014 Jul-Aug;49(4):269-93. doi: 10.3109/10409238.2014.895700. Epub 2014 Mar 10. Crit Rev Biochem Mol Biol. 2014. PMID: 24611808 Free PMC article. Review.
-
Cholesterol catabolism as a therapeutic target in Mycobacterium tuberculosis.Trends Microbiol. 2011 Nov;19(11):530-9. doi: 10.1016/j.tim.2011.07.009. Epub 2011 Sep 15. Trends Microbiol. 2011. PMID: 21924910 Free PMC article. Review.
-
New approaches to tuberculosis--novel drugs based on drug targets related to toll-like receptors in macrophages.Curr Pharm Des. 2014;20(27):4404-17. doi: 10.2174/1381612819666131118163331. Curr Pharm Des. 2014. PMID: 24245765 Review.
-
High-content imaging of Mycobacterium tuberculosis-infected macrophages: an in vitro model for tuberculosis drug discovery.Future Med Chem. 2010 Aug;2(8):1283-93. doi: 10.4155/fmc.10.223. Future Med Chem. 2010. PMID: 21426019
-
Small organic molecules targeting the energy metabolism of Mycobacterium tuberculosis.Eur J Med Chem. 2021 Feb 15;212:113139. doi: 10.1016/j.ejmech.2020.113139. Epub 2020 Dec 29. Eur J Med Chem. 2021. PMID: 33422979 Review.
Cited by
-
Persistence of Intracellular Bacterial Pathogens-With a Focus on the Metabolic Perspective.Front Cell Infect Microbiol. 2021 Jan 14;10:615450. doi: 10.3389/fcimb.2020.615450. eCollection 2020. Front Cell Infect Microbiol. 2021. PMID: 33520740 Free PMC article. Review.
-
Mobile loop dynamics in adenosyltransferase control binding and reactivity of coenzyme B12.Proc Natl Acad Sci U S A. 2020 Dec 1;117(48):30412-30422. doi: 10.1073/pnas.2007332117. Epub 2020 Nov 16. Proc Natl Acad Sci U S A. 2020. PMID: 33199623 Free PMC article.
-
Enzymatic β-Oxidation of the Cholesterol Side Chain in Mycobacterium tuberculosis Bifurcates Stereospecifically at Hydration of 3-Oxo-cholest-4,22-dien-24-oyl-CoA.ACS Infect Dis. 2021 Jun 11;7(6):1739-1751. doi: 10.1021/acsinfecdis.1c00069. Epub 2021 Apr 7. ACS Infect Dis. 2021. PMID: 33826843 Free PMC article.
-
Potential anti-TB investigational compounds and drugs with repurposing potential in TB therapy: a conspectus.Appl Microbiol Biotechnol. 2020 Jul;104(13):5633-5662. doi: 10.1007/s00253-020-10606-y. Epub 2020 May 5. Appl Microbiol Biotechnol. 2020. PMID: 32372202 Review.
-
Identification of the Major Facilitator Superfamily Efflux Pump KpsrMFS in Klebsiella pneumoniae That Is Down-Regulated in the Presence of Multi-Stress Factors.Int J Mol Sci. 2024 Jan 25;25(3):1466. doi: 10.3390/ijms25031466. Int J Mol Sci. 2024. PMID: 38338743 Free PMC article.
References
-
- Russell DG. Mycobacterium tuberculosis: here today, and here tomorrow. Nat Rev Mol Cell Biol. 2001;2(8):569–577. - PubMed
-
- Cambier CJ, Falkow S, Ramakrishnan L. Host evasion and exploitation schemes of Mycobacterium tuberculosis. Cell. 2014;159(7):1497–1509. - PubMed
-
- Peyron P, Vaubourgeix J, Poquet Y, Levillain F, Botanch C, Bardou F, Daffe M, Emile JF, Marchou B, Cardona PJ, de Chastellier C, et al. Foamy macrophages from tuberculous patients' granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence. PLoS Pathog. 2008;4(11):e1000204. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical